|1.||Oversø Hansen, Pernille: 1 article (08/2015)|
|2.||Bek, Toke: 1 article (08/2015)|
|3.||Simonsen, Ulf: 1 article (08/2015)|
|4.||Kringelholt, Sidse: 1 article (08/2015)|
|5.||Dey, Goutam: 1 article (01/2015)|
|6.||Ghosh, Sukhen C: 1 article (01/2015)|
|7.||Parida, Sheetal: 1 article (01/2015)|
|8.||Parekh, Aditya: 1 article (01/2015)|
|9.||Mandal, Mahitosh: 1 article (01/2015)|
|10.||McMurray, John S: 1 article (01/2008)|
01/01/2008 - "The selective EP4 antagonist, GW627368X, induced inhibition of proliferation and invasion of human SUM149 IBC tumor cells beginning at 0.1 microM, with inhibition of proliferation and invasion by MDA-MB-231 non-IBC cells at higher concentrations of GW627368X. "
01/01/2015 - "Oral administration of GW627368X showed significant tumor regression characterized by tumor reduction and induction of apoptosis. "
|2.||Sarcoma (Soft Tissue Sarcoma)
08/01/2015 - "The simultaneous addition of L-NAME or 1400W in combination with ibuprofen, but not GW627368X, reduced hypoxia-induced vasorelaxation additively as compared to the effect of the compounds individually. "
08/01/2015 - "Porcine retinal arterioles with preserved perivascular retinal tissue were mounted in a myograph and were exposed to hypoxia in the presence of one of the following: the general NO synthase inhibitor L-NAME, the selective iNOS inhibitor 1400W, the selective nNOS inhibitor 7-nitroindazole, the general cyclooxygenase (COX) inhibitor ibuprofen or an antagonist to the FP- (AL 8810), DP- (BWA868C), EP1 - (SC-19220), EP2 - (PF-044189) or EP4 receptors (GW627368X). "
|1.||NG-Nitroarginine Methyl Ester (L-NAME)
|2.||Nitric Oxide Synthase (NO Synthase)
|5.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)